Antiretroviral therapy has changed human immunodeficiency virus (HIV) infection from a
near-certainly fatal illness to one that can be managed chronically. More patients are taking …

Context: Lipodystrophies are heterogeneous, genetic or acquired disorders characterized by
selective loss of body fat and predisposition to insulin resistance. The extent of fat loss …

Understanding gut microbiota alterations associated with HIV infection and factors that drive
these alterations may help explain gut-linked diseases prevalent with HIV. 16S rRNA …

Context: Metabolic changes and smoking are common among HIV patients and may confer
increased cardiovascular risk. Objective: The aim of the study was to determine acute …

Background: AIDS-related death and disease rates have declined in the highly active
antiretroviral therapy (HAART) era and remain low; however, current causes of death in …

Background The optimal time for the initiation of antiretroviral therapy for asymptomatic
patients with human immunodeficiency virus (HIV) infection is uncertain. Methods We …

Identifying the immunologic and virologic consequences of discontinuing antiretroviral
therapy in HIV-infected patients is of major importance in developing long-term treatment …

Background. The risk of myocardial infarction (MI) in patients with human immunodeficiency
virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on …

Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD)
among HIV-infected persons, and to investigate any association between such risk factors …

Lipodystrophies, heterogeneous acquired or inherited disorders characterized by the
selective loss of adipose tissue, predispose affected patients to insulin resistance and its …